Loyens & Loeff advised Karo Pharma AB on Swiss aspects of the acquisition of all shares in Hygis SA
Hygis SA is a Swiss distributing company with exclusive distribution rights to Karo Pharma’s brands MultiGyn and MultiMam. This acquisition will further strengthen Karo Pharma’s direct presence in the DACH region.
Karo Pharma is a pharmaceutical company founded in 1987 specialized in sales and marketing of prescription pharmaceuticals and over-the-counter products sold in pharmacies and retail. Karo Pharma is listed on Nasdaq Stockholm Mid Cap.
Loyens & Loeff advised Karo Pharma in the transaction with a team led by Marco Toni and consisted of Fabian Sutter, Valérie Schrämli and Renate Loretan-Bührle.
Marco ToniPartner Attorney at law
Marco Toni, attorney at law, is a partner in our Zurich office. He focuses on domestic and international M&A transactions, private equity, corporate governance and general corporate, stock exchange and capital markets laws.T: +41 43 434 67 15 M: +41 79 557 62 15 E: email@example.com
Fabian SutterPartner Attorney at law, Swiss certified tax expert
Fabian Sutter, attorney at law and Swiss certified tax expert, is an associate in our Zurich office. He focusses on Swiss and international taxation, in particular corporate reorganizations and restructurings, M&A, financing and capital market transactions, transfer pricing, private equity, real estate transactions as well as tax litigation.T: +41 43 434 67 14 M: +41 79 398 76 39 E: firstname.lastname@example.org
Valérie SchrämliAssociate Attorney at law
Valérie, attorney at law, is an associate in our Zurich office and she focuses on domestic and cross-border M&A, private equity and capital market transactions, corporate governance, general corporate law and contractual matters.T: +41 43 434 67 29 E: email@example.com